Biren Amin
Stock Analyst at Piper Sandler
(4.50)
# 1,185
Out of 4,683 analysts
637
Total ratings
48.7%
Success rate
9.5%
Average return
Main Sectors:
Stocks Rated by Biren Amin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OKYO OKYO Pharma | Maintained: Buy | $7 | $1.55 | +351.61% | 3 | Aug 27, 2026 | |
| OCUL Ocular Therapeutix | Maintained: Buy | $31 | $10.77 | +187.84% | 27 | Aug 26, 2026 | |
| KYMR Kymera Therapeutics | Maintained: Buy | $140 | $125.55 | +11.51% | 3 | Aug 20, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | $10 | $2.04 | +390.20% | 23 | Aug 13, 2026 | |
| CNTB Connect Biopharma Holdings | Maintained: Buy | $7 | $2.33 | +200.43% | 2 | Aug 13, 2026 | |
| JSPR Jasper Therapeutics | Initiated Coverage: Buy | $2 | $0.718 | +178.55% | 1 | Aug 12, 2026 | |
| TSHA Taysha Gene Therapies | Maintained: Buy | $12 | $6.02 | +99.34% | 11 | Aug 12, 2026 | |
| IMNM Immunome | Maintained: Buy | $33 | $28.75 | +14.78% | 16 | Aug 12, 2026 | |
| LENZ LENZ Therapeutics | Maintained: Hold | $12 → $7 | $4.78 | +46.44% | 10 | Aug 12, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Maintained: Buy | $21 | $9.26 | +126.78% | 9 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 → $14 | $3.16 | +343.04% | 9 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $111 → $115 | $79.37 | +44.89% | 34 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $3.80 | +189.47% | 4 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $6.19 | +77.71% | 6 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $6 | $2.43 | +146.91% | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $19.46 | +2.77% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 | $34.38 | +106.52% | 14 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $855 → $854 | $814.79 | +4.81% | 46 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $113.72 | -11.19% | 9 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $18.02 | +94.23% | 24 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $0.4237 | +1,552.11% | 8 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $16.90 | +184.02% | 8 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $18 | $9.72 | +85.19% | 16 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $26.71 | +31.04% | 10 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $7 | $4.08 | +71.57% | 3 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $51 | $11.30 | +351.33% | 4 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $70 | $3.89 | n/a | 4 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $142 → $94 | $156.59 | n/a | 44 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $20.68 | n/a | 4 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $0.3122 | n/a | 20 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $19 | $9.43 | n/a | 2 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 → $7 | $8.25 | n/a | 11 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $51 | $4.24 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $59 → $34 | $31.31 | n/a | 2 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $2.36 | n/a | 5 | Feb 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $32 | $4.36 | n/a | 2 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $3.12 | n/a | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 → $109 | $2.57 | n/a | 3 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 → $60 | $8.08 | n/a | 18 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.33 | n/a | 3 | Dec 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $10 | $0.8161 | n/a | 2 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $9 | $3.32 | n/a | 12 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $36 → $18 | $49.16 | n/a | 32 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $61.09 | n/a | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $5.43 | n/a | 4 | May 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.0001 | n/a | 1 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $11 | $3.83 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $58.00 | n/a | 10 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3.5 | $8.25 | n/a | 4 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $1 | $0.001 | n/a | 19 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $7.5 | $40.57 | n/a | 19 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $26 | $0.0001 | n/a | 3 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $14.73 | n/a | 1 | Jun 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $154.33 | n/a | 1 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $155 | $547.29 | n/a | 1 | Jul 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $4.88 | n/a | 1 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $3.42 | n/a | 7 | Jun 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $0.6233 | n/a | 9 | May 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $15 | $38.41 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $8.75 | $15.83 | n/a | 7 | Jan 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 | $7.39 | n/a | 7 | Jan 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.0001 | n/a | 1 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $11 | $63.79 | n/a | 7 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $0.9841 | n/a | 1 | Feb 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 → $7 | $1.26 | n/a | 6 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 | $0.1831 | n/a | 1 | Aug 22, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $73.77 | n/a | 7 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $4 | $56.10 | n/a | 2 | May 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $148.09 | n/a | 1 | Jan 27, 2010 |
OKYO Pharma
Aug 27, 2026
Maintained: Buy
Price Target: $7
Current: $1.55
Upside: +351.61%
Ocular Therapeutix
Aug 26, 2026
Maintained: Buy
Price Target: $31
Current: $10.77
Upside: +187.84%
Kymera Therapeutics
Aug 20, 2026
Maintained: Buy
Price Target: $140
Current: $125.55
Upside: +11.51%
Allogene Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $10
Current: $2.04
Upside: +390.20%
Connect Biopharma Holdings
Aug 13, 2026
Maintained: Buy
Price Target: $7
Current: $2.33
Upside: +200.43%
Jasper Therapeutics
Aug 12, 2026
Initiated Coverage: Buy
Price Target: $2
Current: $0.718
Upside: +178.55%
Taysha Gene Therapies
Aug 12, 2026
Maintained: Buy
Price Target: $12
Current: $6.02
Upside: +99.34%
Immunome
Aug 12, 2026
Maintained: Buy
Price Target: $33
Current: $28.75
Upside: +14.78%
LENZ Therapeutics
Aug 12, 2026
Maintained: Hold
Price Target: $12 → $7
Current: $4.78
Upside: +46.44%
BridgeBio Oncology Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $21
Current: $9.26
Upside: +126.78%
Aug 11, 2026
Rated: Buy
Price Target: $16 → $14
Current: $3.16
Upside: +343.04%
Aug 11, 2026
Rated: Buy
Price Target: $111 → $115
Current: $79.37
Upside: +44.89%
Aug 7, 2026
Maintained: Buy
Price Target: $11
Current: $3.80
Upside: +189.47%
Aug 7, 2026
Maintained: Buy
Price Target: $11
Current: $6.19
Upside: +77.71%
Aug 7, 2026
Maintained: Buy
Price Target: $4 → $6
Current: $2.43
Upside: +146.91%
Aug 6, 2026
Maintained: Hold
Price Target: $20
Current: $19.46
Upside: +2.77%
Jul 30, 2026
Maintained: Buy
Price Target: $71
Current: $34.38
Upside: +106.52%
Jul 9, 2026
Rated: Buy
Price Target: $855 → $854
Current: $814.79
Upside: +4.81%
Jun 29, 2026
Maintained: Buy
Price Target: $101
Current: $113.72
Upside: -11.19%
Jun 23, 2026
Maintained: Buy
Price Target: $35
Current: $18.02
Upside: +94.23%
Jun 2, 2026
Maintained: Buy
Price Target: $7
Current: $0.4237
Upside: +1,552.11%
Jun 1, 2026
Maintained: Buy
Price Target: $48
Current: $16.90
Upside: +184.02%
May 13, 2026
Maintained: Buy
Price Target: $17 → $18
Current: $9.72
Upside: +85.19%
May 13, 2026
Maintained: Buy
Price Target: $35
Current: $26.71
Upside: +31.04%
Mar 30, 2026
Maintained: Hold
Price Target: $5 → $7
Current: $4.08
Upside: +71.57%
Oct 20, 2025
Maintained: Buy
Price Target: $35 → $51
Current: $11.30
Upside: +351.33%
May 19, 2023
Maintained: Buy
Price Target: $63 → $70
Current: $3.89
Upside: n/a
Mar 3, 2022
Downgraded: Hold
Price Target: $142 → $94
Current: $156.59
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: $56
Current: $20.68
Upside: n/a
Jul 23, 2021
Reiterated: Buy
Price Target: $25
Current: $0.3122
Upside: n/a
Mar 17, 2021
Maintained: Buy
Price Target: $14 → $19
Current: $9.43
Upside: n/a
Mar 15, 2021
Rated: Buy
Price Target: $8 → $7
Current: $8.25
Upside: n/a
Mar 12, 2021
Reiterated: Buy
Price Target: $34 → $51
Current: $4.24
Upside: n/a
Feb 16, 2021
Downgraded: Hold
Price Target: $59 → $34
Current: $31.31
Upside: n/a
Feb 10, 2021
Reiterated: Buy
Price Target: $21
Current: $2.36
Upside: n/a
Jan 15, 2021
Reiterated: Buy
Price Target: $27 → $32
Current: $4.36
Upside: n/a
Jan 11, 2021
Initiated Coverage: Buy
Price Target: $51
Current: $3.12
Upside: n/a
Dec 21, 2020
Maintained: Buy
Price Target: $39 → $109
Current: $2.57
Upside: n/a
Dec 21, 2020
Maintained: Buy
Price Target: $43 → $60
Current: $8.08
Upside: n/a
Dec 9, 2020
Downgraded: Hold
Price Target: n/a
Current: $2.33
Upside: n/a
Sep 14, 2020
Downgraded: Hold
Price Target: $15 → $10
Current: $0.8161
Upside: n/a
Aug 7, 2020
Maintained: Hold
Price Target: $10 → $9
Current: $3.32
Upside: n/a
Jul 29, 2020
Maintained: Hold
Price Target: $36 → $18
Current: $49.16
Upside: n/a
Jul 7, 2020
Initiated Coverage: Buy
Price Target: $41
Current: $61.09
Upside: n/a
May 29, 2020
Downgraded: Hold
Price Target: $18 → $2
Current: $5.43
Upside: n/a
Mar 27, 2020
Initiated Coverage: Buy
Price Target: $6
Current: $0.0001
Upside: n/a
Dec 3, 2019
Maintained: Buy
Price Target: $6 → $11
Current: $3.83
Upside: n/a
Nov 8, 2019
Downgraded: Hold
Price Target: $12
Current: $58.00
Upside: n/a
Nov 12, 2018
Reiterated: Hold
Price Target: $4 → $3.5
Current: $8.25
Upside: n/a
Oct 10, 2018
Downgraded: Hold
Price Target: $10 → $1
Current: $0.001
Upside: n/a
Aug 10, 2018
Reiterated: Hold
Price Target: $15 → $7.5
Current: $40.57
Upside: n/a
Jun 18, 2018
Reiterated: Buy
Price Target: $21 → $26
Current: $0.0001
Upside: n/a
Jun 5, 2018
Initiated Coverage: Buy
Price Target: $17
Current: $14.73
Upside: n/a
Mar 19, 2018
Initiated Coverage: Buy
Price Target: $12
Current: $154.33
Upside: n/a
Jul 11, 2017
Initiated Coverage: Buy
Price Target: $155
Current: $547.29
Upside: n/a
Jun 22, 2017
Reiterated: Buy
Price Target: $17
Current: $4.88
Upside: n/a
Jun 6, 2017
Reiterated: Buy
Price Target: $47
Current: $3.42
Upside: n/a
May 15, 2017
Reiterated: Hold
Price Target: $3
Current: $0.6233
Upside: n/a
Mar 10, 2017
Reiterated: Hold
Price Target: $9 → $15
Current: $38.41
Upside: n/a
Jan 18, 2017
Downgraded: Hold
Price Target: $6 → $8.75
Current: $15.83
Upside: n/a
Jan 12, 2017
Reiterated: Hold
Price Target: $1.5
Current: $7.39
Upside: n/a
Mar 9, 2016
Reiterated: Buy
Price Target: $9
Current: $0.0001
Upside: n/a
Mar 9, 2016
Maintained: Buy
Price Target: $12 → $11
Current: $63.79
Upside: n/a
Feb 22, 2016
Maintained: Buy
Price Target: $15
Current: $0.9841
Upside: n/a
Oct 30, 2015
Rated: Buy
Price Target: $6 → $7
Current: $1.26
Upside: n/a
Aug 22, 2014
Downgraded: Hold
Price Target: $5
Current: $0.1831
Upside: n/a
May 15, 2014
Initiated Coverage: Buy
Price Target: $15
Current: $73.77
Upside: n/a
May 2, 2014
Rated: Hold
Price Target: $6 → $4
Current: $56.10
Upside: n/a
Jan 27, 2010
Maintained: Buy
Price Target: $29
Current: $148.09
Upside: n/a